Holen Sie sich die Stockscreener-App
1.30
6.47%
-0.09
Handel nachbörslich:
1.35
0.05
+3.85%
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
14.40%
4.3779
|
5.1146 | 3.115 | 3.4452 | 2.903 |
| Income/Loss From Continuing Operations Before Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
| Income/Loss From Continuing Operations After Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
|
Net Income/Loss
|
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
| Diluted Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
| Basic Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
| Diluted Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):